GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InspireMD Inc (NAS:NSPR) » Definitions » Cyclically Adjusted PB Ratio

NSPR (InspireMD) Cyclically Adjusted PB Ratio : 0.02 (As of May. 28, 2025)


View and export this data going back to 1997. Start your Free Trial

What is InspireMD Cyclically Adjusted PB Ratio?

As of today (2025-05-28), InspireMD's current share price is $2.49. InspireMD's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $125.33. InspireMD's Cyclically Adjusted PB Ratio for today is 0.02.

The historical rank and industry rank for InspireMD's Cyclically Adjusted PB Ratio or its related term are showing as below:

NSPR' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.02   Max: 0.31
Current: 0.02

During the past years, InspireMD's highest Cyclically Adjusted PB Ratio was 0.31. The lowest was 0.01. And the median was 0.02.

NSPR's Cyclically Adjusted PB Ratio is ranked better than
98.19% of 496 companies
in the Medical Devices & Instruments industry
Industry Median: 1.825 vs NSPR: 0.02

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

InspireMD's adjusted book value per share data for the three months ended in Mar. 2025 was $0.953. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $125.33 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


InspireMD Cyclically Adjusted PB Ratio Historical Data

The historical data trend for InspireMD's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InspireMD Cyclically Adjusted PB Ratio Chart

InspireMD Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.02 0.01 0.02 0.02

InspireMD Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.02 0.02

Competitive Comparison of InspireMD's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, InspireMD's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InspireMD's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InspireMD's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where InspireMD's Cyclically Adjusted PB Ratio falls into.


;
;

InspireMD Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

InspireMD's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2.49/125.33
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InspireMD's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, InspireMD's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.953/134.9266*134.9266
=0.953

Current CPI (Mar. 2025) = 134.9266.

InspireMD Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 0.000 101.861 0.000
201612 0.000 101.863 0.000
201703 0.000 102.862 0.000
201706 0.000 103.349 0.000
201709 0.000 104.136 0.000
201712 1,363.500 104.011 1,768.777
201803 208.800 105.290 267.573
201806 455.333 106.317 577.863
201809 223.510 106.507 283.151
201812 171.824 105.998 218.718
201903 331.765 107.251 417.377
201906 59.935 108.070 74.830
201909 34.330 108.329 42.759
201912 20.625 108.420 25.667
202003 12.031 108.902 14.906
202006 5.942 108.767 7.371
202009 4.692 109.815 5.765
202012 3.704 109.897 4.548
202103 5.597 111.754 6.758
202106 5.159 114.631 6.072
202109 4.692 115.734 5.470
202112 4.042 117.630 4.636
202203 3.571 121.301 3.972
202206 3.093 125.017 3.338
202209 2.624 125.227 2.827
202212 2.088 125.222 2.250
202303 1.612 127.348 1.708
202306 2.209 128.729 2.315
202309 2.021 129.860 2.100
202312 1.809 129.419 1.886
202403 1.499 131.776 1.535
202406 1.856 132.554 1.889
202409 1.608 133.029 1.631
202412 1.356 133.157 1.374
202503 0.953 134.927 0.953

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


InspireMD  (NAS:NSPR) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


InspireMD Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of InspireMD's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


InspireMD Business Description

Traded in Other Exchanges
Address
6303 Waterford District Drive, Suite 215, Miami, FL, USA, 33126
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
Executives
Gary S Roubin director 4300 ROCKMORE RD JACKSON, WYOMING WY 83001
Patrick Verta officer: EVP Clinical/Medical Affairs 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Michael Berman director 735 PALAMAR AVENUE, SUNNYVALE CA 94085
Thomas J Kester director C/O INSPIREMD, INC., 321 COLUMBUS AVENUE, BOSTON MA 02116
Paul Stuka director C/O OSIRIS PARTNERS, LLC, ONE LIBERTY SQUARE, 5TH FLOOR, BOSTON MA 02109
Andrea Tommasoli officer: Chief Operating Officer 22, RUE DE LA PLAGE, COLLONGES AU MONT D OR I0 69660
Shane Thomas Gleason officer: VP Global Marketing 18 NORTHAMPTON PL, COTO DE CAZA CA 92679
Kathryn Arnold director 1136 CHESTNUT AVE., WILMETTE IL 60091
Marvin Slosman director, officer: CEO and President 4 MENORAT HAMAOR ST., C/O INSPIREMD, INC., TEL AVIV L3 6744832
Isaac Blech director C/O INSPIREMD, INC., 321 COLUMBUS AVENUE, BOSTON MA 02116
Agustin V Gago officer: EVP, Chief Commercial Officer 256 JERUSALEM AVE, MASSAPEQUA NY 11758
Eric L. Olson officer: VP of Global Sales Operations C/O INSPIREMD, INC., 800 BOYLSTON STREET, 16TH FLOOR, BOSTON MA 02199
Campbell Rogers director C/O INSPIREMD, INC., 800 BOYLSTON STREET, SUITE 16041, BOSTON MA 02199
James J Barry director C/O INSPIREMD, INC., 4 MENORAT HAMAOR ST., TEL AVIV L3 6744832
Eyal Weinstein director C/O LEOREX LTD., P.O.B. 15067 MATAM, HAIFA L3 31905